Clinical Trials in Los Angeles

Showing 15261-15280 of 16,901 trials

Personalized Indicators for Predicting Response to SSRI Treatment in Major Depression (The PRISE-MD Study)

NCT00917059

This study will examine whether measures of brain electrical signals taken after a week of antidepressant medication treatment can predict whether a full treatment regimen will be effective.

Depression

University of California, Los Angeles172 participantsStarted May 2009

Los Angeles, California, United States

COMPLETEDPhase 3< 1 mile

Prescription Opioid Addiction Treatment Study (POATS)

NCT00316277

The purpose of this study is to determine whether treatment outcome for subjects dependent on prescription opioid analgesics can be improved by adding individual drug counseling to the prescription of buprenorphine/naloxone with standard medical management. This will be examined during: a) an initial four-week treatment with taper; b) a 12-week stabilization treatment for those who do not respond successfully to the initial treatment; and c) a long-term follow-up assessment at 1.5 years, 2.5 years, and 3.5 years after treatment.

Opiate DependenceSubstance-related DisordersOpioid-related Disorders

Mclean Hospital653 participantsStarted May 2006

Los Angeles, California, United States • San Francisco, California, United States • Lawrenceburg, Indiana, United States +9 more locations

Personalized Indicators for Predicting Response to SSRI Treatment in Major Depression (The PRISE-MD Study)

Prescription Opioid Addiction Treatment Study (POATS)

Find Trials by Condition in Los Angeles

Chemotherapy in Treating Children With Recurrent or Refractory Sarcomas

O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors

Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma

Computerized Tomographic Colonography Compared With Standard Diagnostic Procedures in Detecting Colorectal Neoplasia

S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium

S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer

Trial of Linaclotide in Patients With Chronic Constipation

FREEDOM DR: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor or as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)

Open Label Continuation Study in Moderate to Severe Psoriasis

Dasatinib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate

Study Evaluating SKI-606 (Bosutinib) In Subjects With Breast Cancer

Efficacy Study of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery

Tirapazamine Plus Cyclophosphamide in Treating Children With Refractory Solid Tumors

Topotecan in Treating Children With Refractory Leukemia

Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia

Efficacy and Safety Study for Subjects With Mild-to-Moderate Alzheimer's Disease

A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer

Sole-Therapy Treatment of Atrial Fibrillation